期刊文献+

1-甲基-3-丙基-4-氨基吡唑-5-甲腈的研究

Study of 1-Methyl-3-propyl-4-aminopyrazole-5-carbonitrile
原文传递
导出
摘要 以1-甲基-3-丙基吡唑-5-甲酸为原料,经酰化、脱水、硝化、还原反应合成了1-甲基-3-丙基-4-氨基吡唑-5-甲腈,然后与醛类缩合得到吡唑并嘧啶酮衍生物.在Pd/C催化氢化1-甲基-3-丙基-4-硝基吡唑-5-甲腈的过程中,利用HPLC和HPLC-HRMS分离检测到硝基还原为氨基过程的3个中间体:羟胺、氧化偶氮、偶氮化合物,提出了可能的还原机理.产物结构经~1H NMR,^(13)C NMR,IR和MS分析表征. 1-Methyl-3-propyl-4-aminopyrazole-5-carbonitrile was synthesized by using 1-methyl-3-propylpyrazole-5-formic as starting materials in four steps reaction including acylation, dehydration, nitrification and reduction. Then pyrazolopyrim- idinone derivatives were obtained from the condensation of 1-methyl-3-propyl-4-aminopyrazole-5-carbonitrile and aldehydes. 1-Methyl-3-propyl-4-nitropyrazole-5-carbonitrile was reduced to amine in the presence of palladium-charcoal. Three interme- diate products, hydroxylamine, azoxypyrazole and azopyrazole, were separated and detected with HPLC and HPLC-HRMS during the formation of amine pyrazole. Possible reduction mechanism was proposed. The structures of products were characterized by 1^H NMR, 13^C NMR, IR spectra and MS.
出处 《有机化学》 SCIE CAS CSCD 北大核心 2016年第7期1611-1616,共6页 Chinese Journal of Organic Chemistry
关键词 1-甲基-3-丙基-4-氨基吡唑-5-甲腈 吡唑并嘧啶酮衍生物 还原机理 1-methyl-3-propyl-4-aminopyrazole-5-carbonitrile pyrazolopyrimidinone derivative reduction mechanism
  • 相关文献

参考文献8

二级参考文献76

  • 1史达清,王菊仙,荣良策,庄启亚,胡宏纹.低价钛引起的邻硝基苯甲酰胺与酮的还原成环反应[J].高等学校化学学报,2004,25(3):462-465. 被引量:4
  • 2阮朗.吡咯杀虫剂的发现及评论[J].农药译丛,1995,17(2):24-31. 被引量:14
  • 3李焱,王玉炉.2-取代苯并噻唑的合成进展[J].有机化学,2006,26(6):878-884. 被引量:13
  • 4李加荣,马淑玲,孙永江,周智明.3,1-苯并噁嗪化合物的合成及晶体结构[J].有机化学,2006,26(7):928-932. 被引量:3
  • 5[1]Beer. A review of the preclinical development of zaleplon, a novel non-benzodiazepine hypnotic for the treatment of insomnia. CNS Drug Reviews, 1997; 3: 210~215.
  • 6[2]Sanger DJ ,Morel E,Perrault G.Comparison of the pharmacological profiles of the hypnotic drugs,zaleppon and zolpidem .Eur J Pharmacol, 1996; 313(1~2):35~42.
  • 7[3]Jacques G, France V. Pharmacokinetics and anticonvulsant effect of a new hypnotic ,CL 284,846,in rats. Pharmaceutical Research, 1995; 12: 1592~1597.
  • 8[4]Amy S R, Mona D,et al. Zaleplon pharmacokinetics and absolute bioavailability. Biopharm Drug Dispos, 1999; 20:171~175.
  • 9[5]David J G, Jerold S H,et al.Comparative kinetics and dynamics of zaleplon, zolpidem,and placebo.Clinical Pharmacology & Therzpeutics, 1998; 553~560.
  • 10[6]Kimberly E. Vanover, et al,Evaluation of the discriminative stimulus effects of the novel sedative-hypnotic. Psychopharmacology, 1994; 115: 289~296.

共引文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部